CADM1 as a Candidate Gene for Neuroblastoma
Author Information
Author(s): Evi Michels, Jasmien Hoebeeck, Katleen De Preter, Alexander Schramm, Bénédicte Brichard, Anne De Paepe, Angelika Eggert, Geneviève Laureys, Jo Vandesompele, Frank Speleman
Primary Institution: Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium
Hypothesis
Is CADM1 a significant candidate tumor suppressor gene in neuroblastoma?
Conclusion
CADM1 is identified as a strong candidate neuroblastoma suppressor gene, warranting further functional studies.
Supporting Evidence
- CADM1 expression has prognostic significance in neuroblastoma.
- Differential expression of CADM1 was noted in unfavorable neuroblastoma versus normal neuroblasts.
- Methylation analysis provided no evidence for a two-hit mechanism in 11q deleted cell lines.
Takeaway
Researchers found a gene called CADM1 that might help stop a type of childhood cancer called neuroblastoma from growing.
Methodology
The study analyzed chromosome 11 status in 100 neuroblastoma tumors and 29 cell lines using BAC array and performed meta-analysis on gene expression datasets.
Limitations
The study does not conclusively establish the mechanism of CADM1 inactivation in neuroblastoma.
Participant Demographics
The study included 100 primary neuroblastoma tumors of various stages.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website